Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases

MLA

Saeedeh Ghorbanalipoor, et al. “Cutaneous Kinase Activity Correlates with Treatment Outcomes Following PI3K Delta Inhibition in Mice with Experimental Pemphigoid Diseases.” Frontiers in Immunology, vol. 13, Sept. 2022. EBSCOhost, https://doi.org/10.3389/fimmu.2022.865241.

APA

Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, Mayumi Kamaguchi, Colin Osterloh, Manuela Pigors, Natalie Gross, Stanislav Khil’chenko, Anika Kasprick, Sabrina Patzelt, Diana Wortmann, Ibrahim O. Ibrahim, Kentaro Izumi, Stephanie Goletz, Katharina Boch, Kathrin Kalies, Katja Bieber, Paul Smith, Enno Schmidt, & Ralf J. Ludwig. (2022). Cutaneous kinase activity correlates with treatment outcomes following PI3K delta inhibition in mice with experimental pemphigoid diseases. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.865241

Chicago

Saeedeh Ghorbanalipoor, Shirin Emtenani, Melissa Parker, Mayumi Kamaguchi, Colin Osterloh, Manuela Pigors, Natalie Gross, et al. 2022. “Cutaneous Kinase Activity Correlates with Treatment Outcomes Following PI3K Delta Inhibition in Mice with Experimental Pemphigoid Diseases.” Frontiers in Immunology 13 (September). doi:10.3389/fimmu.2022.865241.